Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
O15264
UPID:
MK13_HUMAN
Alternative names:
Mitogen-activated protein kinase p38 delta; Stress-activated protein kinase 4
Alternative UPACC:
O15264; O14739; O15124; Q5U4A5; Q6FI46; Q9UNU0
Background:
Mitogen-activated protein kinase 13 (MAPK13), also known as p38 delta, is a serine/threonine kinase pivotal in the MAP kinase signal transduction pathway. It is involved in cellular responses to extracellular stimuli, including pro-inflammatory cytokines and physical stress, leading to the activation of transcription factors such as ELK1 and ATF2. MAPK13 phosphorylates a wide range of proteins, playing roles in protein translation regulation, cytoskeletal remodeling, UV irradiation response, keratinocyte differentiation, apoptosis, and skin tumor development.
Therapeutic significance:
Understanding the role of Mitogen-activated protein kinase 13 could open doors to potential therapeutic strategies.